| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print February 13, 2003
Chemistry and Biochemistry, Florida State University, Tallahassee, FL 32306-4390
Corresponding Author: sang{at}chem.fsu.edu
This work has explored a putative biochemical mechanism by which endometase/matrilysin-2/matrix metalloproteinase-26 (MMP-26) may promote human prostate cancer cell invasion. Here, we showed that the levels of MMP-26 protein in human prostate carcinomas from multiple patients were significantly higher than those in prostatitis, benign prostate hyperplasia, and normal prostate glandular tissues. The role of MMP-26 in prostate cancer progression is unknown. MMP-26 was capable of activating pro-MMP-9 by cleavage at the Ala93 -Met94 site of the prepro-enzyme. This activation proceeded in a time- and dose-dependent manner, facilitating the efficient cleavage of fibronectin by MMP-9. The activated MMP-9 products generated by MMP-26 appeared more stable than those cleaved by MMP-7 under the conditions tested. To investigate the contribution of MMP-26 to cancer cell invasion via the activation of MMP-9, highly invasive and metastatic human prostate carcinoma cells, androgen-repressed prostate cancer (ARCaP) cells, were selected as a working model. ARCaP cells express both MMP-26 and MMP-9. Specific anti-MMP-26 and anti-MMP-9 functional blocking antibodies both reduced the invasiveness of ARCaP cells across fibronectin or type IV collagen. Furthermore, the introduction of MMP-26 antisense cDNA into ARCaP cells significantly reduced the MMP-26 protein level in these cells and strongly suppressed the invasiveness of ARCaP cells. Double immunofluorescence staining and confocal laser scanning microscopic images revealed that MMP-26 and MMP-9 were co-localized in parental and MMP-26 sense-transfected ARCaP cells. Moreover, MMP-26 and MMP-9 proteins were both expressed in the same human prostate carcinoma tissue samples examined. These results indicate that MMP-26 may be a physiological and pathological activator of pro-MMP-9, and the activation of pro-MMP-9 by MMP-26 may be an important mechanism contributing to the invasive capabilities of prostate carcinomas.
J. Biol. Chem, 10.1074/jbc.M210975200
Submitted on October 28, 2002
Revised on February 13, 2003
Accepted on February 13, 2003
Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Amos, M. Mut, C. G. diPierro, J. E. Carpenter, A. Xiao, Z. A. Kohutek, G. T. Redpath, Y. Zhao, J. Wang, M. E. Shaffrey, et al. Protein Kinase C-{alpha} Mediated Regulation of Low-Density Lipoprotein Receptor Related Protein and Urokinase Increases Astrocytoma Invasion Cancer Res., November 1, 2007; 67(21): 10241 - 10251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. M. Hussaini, C. Trotter, Y. Zhao, R. Abdel-Fattah, S. Amos, A. Xiao, C. U. Agi, G. T. Redpath, Z. Fang, G. K.K. Leung, et al. Matrix Metalloproteinase-9 Is Differentially Expressed in Nonfunctioning Invasive and Noninvasive Pituitary Adenomas and Increases Invasion in Human Pituitary Adenoma Cell Line Am. J. Pathol., January 1, 2007; 170(1): 356 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Pilka, V. Noskova, H. Domanski, C. Andersson, S. Hansson, and B. Casslen Endometrial TIMP-4 mRNA is expressed in the stroma, while TIMP-4 protein accumulates in the epithelium and is released to the uterine fluid Mol. Hum. Reprod., August 1, 2006; 12(8): 497 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Y. Savinov, A. G. Remacle, V. S. Golubkov, M. Krajewska, S. Kennedy, M. J. Duffy, D. V. Rozanov, S. Krajewski, and A. Y. Strongin Matrix Metalloproteinase 26 Proteolysis of the NH2-Terminal Domain of the Estrogen Receptor {beta} Correlates with the Survival of Breast Cancer Patients. Cancer Res., March 1, 2006; 66(5): 2716 - 2724. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zi, Y. Guo, A. R. Simoneau, C. Hope, J. Xie, R. F. Holcombe, and B. H. Hoang Expression of Frzb/Secreted Frizzled-Related Protein 3, a Secreted Wnt Antagonist, in Human Androgen-Independent Prostate Cancer PC-3 Cells Suppresses Tumor Growth and Cellular Invasiveness Cancer Res., November 1, 2005; 65(21): 9762 - 9770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Dong, R. D. Bonfil, S. Chinni, X. Deng, J. C. Trindade Filho, M. Bernardo, U. Vaishampayan, M. Che, B. F. Sloane, S. Sheng, et al. Matrix Metalloproteinase Activity and Osteoclasts in Experimental Prostate Cancer Bone Metastasis Tissue Am. J. Pathol., April 1, 2005; 166(4): 1173 - 1186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Qiu, S.-X. Bai, M.-r. Zhao, X.-q. Wu, Y.-G. Zhao, Q.-X. A. Sang, and Y.-L. Wang Spatio-Temporal Expression of Matrix Metalloproteinase-26 in Human Placental Trophoblasts and Fetal Red Cells During Normal Placentation Biol Reprod, April 1, 2005; 72(4): 954 - 959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Li, A. Y. Savinov, D. V. Rozanov, V. S. Golubkov, H. Hedayat, T. I. Postnova, N. V. Golubkova, Y. Linli, S. Krajewski, and A. Y. Strongin Matrix Metalloproteinase-26 Is Associated with Estrogen-Dependent Malignancies and Targets {alpha}1-Antitrypsin Serpin Cancer Res., December 1, 2004; 64(23): 8657 - 8665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yamamoto, A. Vinitketkumnuen, Y. Adachi, H. Taniguchi, T. Hirata, N. Miyamoto, K. Nosho, A. Imsumran, M. Fujita, M. Hosokawa, et al. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma Carcinogenesis, December 1, 2004; 25(12): 2353 - 2360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-G. Zhao, A.-Z. Xiao, H. I. Park, R. G. Newcomer, M. Yan, Y.-G. Man, S. C. Heffelfinger, and Q.-X. A. Sang Endometase/Matrilysin-2 in Human Breast Ductal Carcinoma in Situ and Its Inhibition by Tissue Inhibitors of Metalloproteinases-2 and -4: A Putative Role in the Initiation of Breast Cancer Invasion Cancer Res., January 15, 2004; 64(2): 590 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. I. Park, Y. Jin, D. R. Hurst, C. A. Monroe, S. Lee, M. A. Schwartz, and Q.-X. A. Sang The Intermediate S1' Pocket of the Endometase/Matrilysin-2 Active Site Revealed by Enzyme Inhibition Kinetic Studies, Protein Sequence Analyses, and Homology Modeling J. Biol. Chem., December 19, 2003; 278(51): 51646 - 51653. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |
